A functional genomic screen identifies cellular cofactors of hepatitis C virus replication.

Hepatitis C virus (HCV) chronically infects 3% of the world's population, and complications from HCV are the leading indication for liver transplantation. Given the need for better anti-HCV therapies, one strategy is to identify and target cellular cofactors of the virus lifecycle. Using a genome-wide siRNA library, we identified 96 human genes that support HCV replication, with a significant number of them being involved in vesicle organization and biogenesis. Phosphatidylinositol 4-kinase PI4KA and multiple subunits of the COPI vesicle coat complex were among the genes identified. Consistent with this, pharmacologic inhibitors of COPI and PI4KA blocked HCV replication. Targeting hepcidin, a peptide critical for iron homeostasis, also affected HCV replication, which may explain the known dysregulation of iron homeostasis in HCV infection. The host cofactors for HCV replication identified in this study should serve as a useful resource in delineating new targets for anti-HCV therapies.

[1]  K. Kirkegaard,et al.  Inhibition of poliovirus RNA synthesis by brefeldin A , 1992, Journal of virology.

[2]  P. Schultz,et al.  Identification of Human Kinases Involved in Hepatitis C Virus Replication by Small Interference RNA Library Screening* , 2008, Journal of Biological Chemistry.

[3]  K. Hoe,et al.  Systematic identification of hepatocellular proteins interacting with NS5A of the hepatitis C virus. , 2004, Journal of biochemistry and molecular biology.

[4]  R. Bartenschlager,et al.  Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons , 2003, Journal of Virology.

[5]  L. Bianchi,et al.  Expression of Hepatitis C Virus Proteins Induces Distinct Membrane Alterations Including a Candidate Viral Replication Complex , 2002, Journal of Virology.

[6]  N. Enomoto,et al.  Expressional screening of interferon‐stimulated genes for antiviral activity against hepatitis C virus replication , 2006, Journal of viral hepatitis.

[7]  K. Shimotohno,et al.  Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. , 2005, Molecular cell.

[8]  K. Naka,et al.  Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. , 2005, Biochemical and biophysical research communications.

[9]  K. Kaila,et al.  A Novel N-terminal Isoform of the Neuron-specific K-Cl Cotransporter KCC2* , 2007, Journal of Biological Chemistry.

[10]  S. Zeuzem,et al.  Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study. , 2006, Gastroenterology.

[11]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[12]  C. Wychowski,et al.  Inhibition of Hepatitis C Virus Infection in Cell Culture by Small Interfering RNAs , 2007, Molecular Therapy.

[13]  F. Wieland,et al.  COPI-mediated Transport , 2006, The Journal of Membrane Biology.

[14]  A. Molla,et al.  Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology , 2007, Hepatology.

[15]  R. König,et al.  Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication , 2008, Cell.

[16]  K. Goto,et al.  Cloning, Expression, and Localization of 230-kDa Phosphatidylinositol 4-Kinase (*) , 1996, The Journal of Biological Chemistry.

[17]  K. Catt,et al.  Isolation and Molecular Cloning of Wortmannin-sensitive Bovine Type III Phosphatidylinositol 4-Kinases* , 1997, The Journal of Biological Chemistry.

[18]  N. Enomoto,et al.  Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha. , 2004, The Journal of infectious diseases.

[19]  Joseph D. Puglisi,et al.  The Pathway of HCV IRES-Mediated Translation Initiation , 2004, Cell.

[20]  S. Schreiber,et al.  A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication. , 2007, Gastroenterology.

[21]  J. Lieberman,et al.  Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2007, Science.

[22]  R. Mulligan,et al.  A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Norbert Perrimon,et al.  COPI Activity Coupled with Fatty Acid Biosynthesis Is Required for Viral Replication , 2006, PLoS pathogens.

[24]  F. Chisari,et al.  Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion , 2007, Journal of Virology.

[25]  T. Dragic,et al.  Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles , 2006, Journal of Virology.

[26]  Anne E Carpenter,et al.  A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen , 2006, Cell.

[27]  Amy S. Espeseth,et al.  Genome-scale RNAi screen for host factors required for HIV replication. , 2008, Cell host & microbe.

[28]  Elizabeta Nemeth,et al.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. , 2004, The Journal of clinical investigation.

[29]  John D. Storey.  A direct approach to false discovery rates , 2002 .

[30]  J. Erickson,et al.  The γ-subunit of the coatomer complex binds Cdc42 to mediate transformation , 2000, Nature.

[31]  J. Erickson,et al.  The gamma-subunit of the coatomer complex binds Cdc42 to mediate transformation. , 2000, Nature.

[32]  T. Balla,et al.  Phosphatidylinositol 4-kinases: old enzymes with emerging functions. , 2006, Trends in cell biology.

[33]  M. Burritt,et al.  Liver Hepcidin mRNA Correlates With Iron Stores, but Not Inflammation, in Patients With Chronic Hepatitis C , 2005, Journal of clinical gastroenterology.

[34]  J. A. Payne,et al.  Molecular Characterization of a Putative K-Cl Cotransporter in Rat Brain , 1996, The Journal of Biological Chemistry.

[35]  R. Bartenschlager,et al.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.

[36]  R. Crabbé,et al.  The cyclophilin inhibitor Debio‐025 shows potent anti–hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus , 2008, Hepatology.

[37]  Jerry Kaplan,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.

[38]  Chris Sander,et al.  Cellular cofactors affecting hepatitis C virus infection and replication , 2007, Proceedings of the National Academy of Sciences.

[39]  N. Kato,et al.  DDX3 DEAD-Box RNA Helicase Is Required for Hepatitis C Virus RNA Replication , 2007, Journal of Virology.

[40]  S. Hanash,et al.  Modification of Host Lipid Raft Proteome upon Hepatitis C Virus Replication*S , 2006, Molecular & Cellular Proteomics.

[41]  L. Cantley,et al.  Subcellular Locations of Phosphatidylinositol 4-Kinase Isoforms* , 1997, The Journal of Biological Chemistry.